Vaccines have been a central focus for Trump's health leaders, but large-cap players aren't feeling the sting.

Delgocitinib cream had superior efficacy and a better safety profile compared with oral alitretinoin for the treatment of ...

Jenny Strasburg is a reporter in London, where she writes for The Wall Street Journal about oil and gas, climate, the ...

EAGLE-1 trial data shows gepotidacin’s potential in treating gonorrhoea, for which no new antibiotics have been approved ...

Oncology experts discuss de-escalation strategies that can reduce toxicity, save a billion in healthcare costs, and make lung ...

The first phase 3 trials are due to start in the first half of next year, using devices manufactured at GSK’s facility in Evreux, France. “If successful, this could lead to regulatory ...

GlaxoSmithKline recently held a high-level scientific conference in conjunction with the launch of “Bexsero,” the first ...

Trump's sweeping tariff measures have shaken the global economy, though, leaving many investors nursing huge losses.

Mobico shares today skidded 21% after the National Express owner announced the sale of its North American school bus ...

Both AstraZeneca and GSK rely on the US for a large portion of ... while Swiss firm Roche fell 5.8 per cent, and France’s Sanofi slipped 6.9 per cent. The rout also caught the US pharma sector ...

France has accused Donald Trump of “interference ... BAE Systems, Rolls-Royce, BP and GSK are all among the US Government’s top 100 federal contractors, according to the General Services ...

The chronic obstructive pulmonary disease (COPD) market across the seven major markets (7MM: US, France, Germany, Italy, ...